Literature DB >> 14322885

IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.

S GARD, G CARLSTROEM, R LAGERCRANTZ, E NORRBY.   

Abstract

Entities:  

Keywords:  COMPLEMENT FIXATION TESTS; HEMAGGLUTINATION INHIBITION TESTS; IMMUNITY; MEASLES; MEASLES VACCINE; NEUTRALIZATION TESTS; VACCINATION COMPLICATIONS

Mesh：

Substances：

Year:  1965        PMID： 14322885     DOI： 10.1007/bf01253829

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN： 0003-9012


× No keyword cloud information.
  16 in total

1.  SEPARATION OF MEASLES VIRUS COMPONENTS BY EQUILIBRIUM CENTRIFUGATION IN CSCL GRADIENTS. II. STUDIES ON THE LARGE AND THE SMALL HEMAGGLUTININ.

Authors:  E C NORRBY; P MAGNUSSON; L G FALKSVEDEN; M GROENBERG
Journal:  Arch Gesamte Virusforsch       Date:  1964-03-13

2.  SEPARATION OF MEASLES VIRUS COMPONENTS BY EQUILIBRIUM CENTRIFUGATION IN CSCL GRADIENTS. I. CRUDE AND TWEEN AND ETHER TREATED CONCENTRATED TISSUE CULTURE MATERIAL.

Authors:  E NORRBY
Journal:  Arch Gesamte Virusforsch       Date:  1964

3.  MEASLES VACCINATION. I. SEROLOGIC RESPONSES TO AN INACTIVATED VACCINE.

Authors:  E NORRBY; R LAGERCRANTZ; S GARD; G CARLSTROEM
Journal:  Arch Gesamte Virusforsch       Date:  1963-08-26

4.  MEASLES EXPOSURE AMONG VACCINE RECIPIENTS. RESPONSE TO MEASLES EXPOSURE AND ANTIBODY PERSISTENCE AMONG RECIPIENTS OF MEASLES VACCINES.

Authors:  V A FULGINITI; C H KEMPE
Journal:  Am J Dis Child       Date:  1963-11

5.  Inactivated measles virus vaccine. III. A field trial in young school children.

Authors:  W WINKELSTEIN; R JENSS; G E GRESHAM; D T KARZON; W E MOSHER
Journal:  JAMA       Date:  1962-02-10       Impact factor: 56.272

6.  Hemagglutination by measles virus. III. Identification of two different hemagglutinins.

Authors:  E NORRBY
Journal:  Virology       Date:  1963-02       Impact factor: 3.616

7.  Protective value of inactivated measles vaccine.

Authors:  H A FELDMAN
Journal:  Am J Dis Child       Date:  1962-03

8.  Serologic response of children to in-activated measles vaccine.

Authors:  C H CARTER; T J CONWAY; D CORNFELD; D G IEZZONI; C H KEMPE; C MOSCOVICI; L W RAUH; A J VIGNEC; J WARREN
Journal:  JAMA       Date:  1962-03-17       Impact factor: 56.272

9.  Field trial of inactivated measles vaccine.

Authors:  D T KARZON; W WINKELSTEIN; R JENSS; G E GRESHAM; W E MOSHER
Journal:  Am J Dis Child       Date:  1962-03

10.  Inactivated measles virus vaccine. II. Prevention of natural and experimental measles with the vaccine.

Authors:  H A FELDMAN; A NOVACK; J WARREN
Journal:  JAMA       Date:  1962-02-10       Impact factor: 56.272
View more
  3 in total

1.  Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.

Authors:  Martin J Hicks; Bishnu P De; Jonathan B Rosenberg; Jesse T Davidson; Amira Y Moreno; Kim D Janda; Sunmee Wee; George F Koob; Neil R Hackett; Stephen M Kaminsky; Stefan Worgall; Miklos Toth; Jason G Mezey; Ronald G Crystal
Journal:  Mol Ther       Date:  2011-01-04       Impact factor: 11.454

2.  Immunobiologic hetertypic activity associated with viral and soluble components of bovine virus diarrhea virus.

Authors:  F J Volenec; B E Sheffy; J A Baker
Journal:  Arch Gesamte Virusforsch       Date:  1972

3.  The effect of nonaqueous solvents on the quaternary structure of viruses: disruption of adenovirus type 5 by formamide. (brief report).

Authors:  A R Neurath; J T Stasny; B A Rubin; F P Wiener
Journal:  Arch Gesamte Virusforsch       Date:  1969
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.